Rayence Co

Rayence Co Net Tangible Assets

The Net Tangible Assets of Rayence Co (228850.KQ) as of Nov 7, 2026 is 236.96 B KRW. In the previous year, Net Tangible Assets was 236.48 B KRW — a change of 0.20% (higher).

Net Tangible Assets

236.96 BKRW

YoY

0.20%

Last updated:

Net Tangible Assets of Rayence Co is 2025 236.96 B KRW. Net Tangible Assets of Rayence Co was 2024 236.48 B KRW. It decreases by 0.20% higher compared to the previous year.

The Rayence Co Net Tangible Assets history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Net Tangible Assets
Date
Net Tangible Assets
Jan 1, 2018
162.62 B KRW
Jan 1, 2019
171.65 B KRW
Jan 1, 2020
169.75 B KRW
Jan 1, 2021
190.61 B KRW
Jan 1, 2022
218.33 B KRW
Jan 1, 2023
233.48 B KRW
Jan 1, 2024
236.48 B KRW
Jan 1, 2025
236.96 B KRW
The Rayence Co Net Tangible Assets history
YEARNet Tangible AssetsYoY
236.96 BKRW+0.20%
236.48 BKRW+1.28%
233.48 BKRW+6.94%
218.33 BKRW+14.54%
190.61 BKRW+12.29%
169.75 BKRW-1.11%
171.65 BKRW+5.55%
162.62 BKRW+4.09%
156.23 BKRW+6.19%
147.12 BKRW+191.57%
50.46 BKRW+21.19%
41.64 BKRW—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Rayence Co Stock analysis

What does Rayence Co do? Rayence Co., Ltd. generates revenue through the manufacturing and sale of x-ray detectors, including TFT and CMOS detectors under brand names such as 1012WCA, 17SCC/SGC, 1215CF, 1501CF, and 0712CF. The company also produces intra oral sensors branded as Ez1.0 and Ez1.5, along with mammography machines under the 1724CM and 2434CM series. These products are distributed to both domestic and international markets, serving healthcare providers and medical facilities that require diagnostic imaging equipment. The primary customers for Rayence's detectors and sensors are hospitals, clinics, and medical imaging centers seeking advanced x-ray technology. The firm's product portfolio targets the medical imaging segment, focusing on applications such as dental diagnostics with intra oral sensors and radiological imaging with mammography machines. Revenue streams are derived from direct sales of these branded products to healthcare institutions across multiple regions. Rayence's business model centers on selling specialized medical imaging equipment under its own brand names, with no mention of third-party partnerships or additional services. The company's revenue is directly tied to the purchase of its branded x-ray detectors, intra oral sensors, and mammography machines by healthcare providers who require high-quality diagnostic tools for patient care. Rayence Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Rayence Co stock

Net Tangible Assets of Rayence Co is 236.96 B KRW in 2025.

Net Tangible Assets of Rayence Co changed from 236.48 B KRW to 236.96 B KRW, representing a 0.20% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Net Tangible Assets Rayence Co since 2006 – with annual values, charts, and detailed analysis.

Net tangible assets equal total assets minus intangible assets, goodwill, and liabilities. They represent the physical asset backing of a company.

Net Tangible Assets's KRW is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Net Tangible Assets's Rayence Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Rayence Co

All Key Metrics — Rayence Co